Search

Your search keyword '"Makoto M. Jones"' showing total 99 results

Search Constraints

Start Over You searched for: Author "Makoto M. Jones" Remove constraint Author: "Makoto M. Jones"
99 results on '"Makoto M. Jones"'

Search Results

1. Incorporating social determinants of health into transmission modeling of COVID-19 vaccine in the US: a scoping review

2. Disparities in COVID-19 related outcomes in the United States by race and ethnicity pre-vaccination era: an umbrella review of meta-analyses

Catalog

Books, media, physical & digital resources

3. Epidemiology and outcomes associated with carbapenem-resistant Acinetobacter baumannii and carbapenem-resistant Pseudomonas aeruginosa: a retrospective cohort study

4. Treatment effectiveness of antibiotic therapy in Veterans with multidrug-resistant Acinetobacter spp. bacteremia

5. Increased carbapenemase testing following implementation of national VA guidelines for carbapenem-resistant Enterobacterales (CRE)

6. Antimicrobial Nonsusceptibility of Gram-Negative Bloodstream Isolates, Veterans Health Administration System, United States, 2003–2013

7. Regional variations in fluoroquinolone non-susceptibility among Escherichia coli bloodstream infections within the Veterans Healthcare Administration

11. Treatment of extensively-drug resistant (XDR) Acinetobacter and impact on clinical outcomes in U.S. veterans affairs (VA) medical centers

12. Lack of correlation between standardized antimicrobial administration ratios (SAARs) and healthcare-facility–onset Clostridioides difficile infection rates in Veterans Affairs medical facilities

14. Performance of infectious diseases specialists, hospitalists, and other internal medicine physicians in antimicrobial case-based scenarios: Potential impact of antimicrobial stewardship programs at 16 Veterans' Affairs medical centers

15. 2234. Clinical Significance of Staphylococcus aureus Bacteriuria without Bacteremia

16. 1667. The Accuracy of Hospital-Onset Bacteremia and Candidemia Metric Variants Across Hospitals

17. Hospital coronavirus disease 2019 (COVID-19) public health reporting: Lessons from validation of an automated surveillance tool to facilitate data collection

18. Healthcare-Associated Infections in Veterans Affairs Acute and Long-Term Healthcare Facilities During the Coronavirus Disease 2019 (COVID-19) Pandemic

19. Hospital COVID-19 Public Health Reporting: Lessons from Validation of an Automated Surveillance Tool to Facilitate Data Collection

20. Launching into clinical space with medspaCy: a new clinical text processing toolkit in Python

21. Trends in Illness Severity, Hospitalization, and Mortality for Community-Onset Pneumonia at 118 US Veterans Affairs Medical Centers

22. Temporal Trends in Antimicrobial Prescribing During Hospitalization for Potential Infection and Sepsis

23. Validation of the SHEA/IDSA severity criteria to predict poor outcomes among inpatients and outpatients with

24. 493. Laboratory Evaluation and Epidemiology of Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae in Department of Veterans Affairs, 2017

25. Epidemiology of nontuberculous mycobacterial infections in the U.S. Veterans Health Administration.

26. A cross-sectional survey of Department of Veterans Affairs laboratory practices for identification of carbapenem-resistant Acinetobacter baumannii and Pseudomonas aeruginosa .

27. Pneumonia diagnosis performance in the emergency department: a mixed-methods study about clinicians' experiences and exploration of individual differences and response to diagnostic performance feedback.

28. Facility- and patient-level factors associated with implementation of contact precautions in hospitalized VA patients with positive CRE cultures.

29. A framework for inferring and analyzing pharmacotherapy treatment patterns.

30. A Linguistic Analysis Examining the Impact of COVID-19 on Pneumonia Diagnosis and Disease Models.

31. Impact of Reducing Time-to-Antibiotics on Sepsis Mortality, Antibiotic Use, and Adverse Events.

32. Development and evaluation of an interoperable natural language processing system for identifying pneumonia across clinical settings of care and institutions.

33. Comparative effectiveness of antibiotic therapy for carbapenem-resistant Enterobacterales (CRE) bloodstream infections in hospitalized US veterans.

34. Quantifying the breadth of antibiotic exposure in sepsis and suspected infection using spectrum scores.

35. Outpatient treatment and clinical outcomes of bacteriuria in veterans: A retrospective cohort analysis.

36. A flexible framework for visualizing and exploring patient misdiagnosis over time.

37. Infectious Disease Consults of Pseudomonas aeruginosa Bloodstream Infection and Impact on Health Outcomes.

38. Pre-endoscopy coronavirus disease 2019 screening and severe acute respiratory syndrome coronavirus-2 nucleic acid amplification testing in the Veterans Affairs healthcare system: clinical practice patterns, outcomes, and relationship to procedure volume.

39. A survey of infection control strategies for carbapenem-resistant Enterobacteriaceae in Department of Veterans' Affairs facilities.

40. Analysis of a national response to a White House directive for ending veteran suicide.

41. Positive Predictive Value of COVID-19 ICD-10 Diagnosis Codes Across Calendar Time and Clinical Setting.

42. Risk Factors Associated With Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Positive Cultures in a Cohort of US Veterans.

43. ReHouSED: A novel measurement of Veteran housing stability using natural language processing.

44. Automated Travel History Extraction From Clinical Notes for Informing the Detection of Emergent Infectious Disease Events: Algorithm Development and Validation.

45. Association Between Contact Precautions and Transmission of Methicillin-Resistant Staphylococcus aureus in Veterans Affairs Hospitals.

46. Attributable Cost of Healthcare-Associated Methicillin-Resistant Staphylococcus aureus Infection in a Long-term Care Center.

47. Expanding an Economic Evaluation of the Veterans Affairs (VA) Methicillin-resistant Staphylococcus aureus (MRSA) Prevention Initiative to Include Prevention of Infections From Other Pathogens.

48. Use of Oral Vancomycin for Clostridioides difficile Infection and the Risk of Vancomycin-Resistant Enterococci.

49. Potential Impact of Hospital-acquired Pneumonia Guidelines on Empiric Antibiotics. An Evaluation of 113 Veterans Affairs Medical Centers.

50. Variation and trends in transmission dynamics of Methicillin-resistant Staphylococcus aureus in veterans affairs hospitals and nursing homes.